Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Novartis Ag (NVS)

Weekly Buzz:FDA Clears Tab-cel Path, Arvinas Wins PROTAC Nod, Novartis Cuts Jobs, Roche Buys PathAI 5/8/2026 8:17:14 AM

Novartis Plans Closure Of Wehr Manufacturing Site By 2028 5/6/2026 3:13:37 AM

Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA 4/30/2026 9:47:31 AM

Novartis AG Bottom Line Drops In Q1 4/28/2026 2:08:20 AM

Novartis Q1 Core EPS Declines To $1.99 From $2.28 Last Year 4/28/2026 1:52:43 AM

Novartis Receives European Commission Approval For Rhapsido In Chronic Spontaneous Urticaria 4/27/2026 4:46:20 AM

Novartis Bags European Commission Approval For Rhapsido In Chronic Spontaneous Urticaria 4/27/2026 3:41:38 AM

Novartis Pulls EMA Filing For New Pluvicto Use After CHMP Pushback 4/24/2026 2:22:52 PM

Novartis' Itvisma Moves Closer To EU Approval With Positive CHMP Opinion 4/24/2026 10:56:05 AM

Novartis Secures WHO Nod For Infant Malaria Therapy Coartem Baby 4/24/2026 4:01:49 AM

Novartis To Expand Community Health Programs To Over 30 Countries By 2030 4/9/2026 2:17:37 AM

Novartis Expands Health Programs To Tackle Heart Disease, Cancer In 30+ Nations By 2030 4/9/2026 1:59:33 AM

Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS 4/3/2026 5:10:06 AM

Novartis: Fabhalta Cut Kidney Function Decline By 49.3% In IgAN 3/30/2026 7:06:37 AM

Novartis To Acquire Excellergy, Expanding Allergy Leadership 3/27/2026 8:41:15 AM

Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal 3/20/2026 10:13:56 AM

Novartis To Acquire SNV4818 In Up To $3 Bln Deal To Boost Breast Cancer Pipeline 3/20/2026 3:31:05 AM

Novartis To Buy Pikavation Therapeutics With PI3Ka Inhibitor From Synnovation For $2 Bln Upfront 3/20/2026 2:55:28 AM

Novartis Gains FDA Approval For Cosentyx In Pediatric Hidradenitis Suppurativa 3/16/2026 3:17:07 AM

Novartis: Pluvicto Shows Effectiveness In Real-world Studies 2/24/2026 8:35:58 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap